ROCHESTER, Minn., April 6, 2022 (SEND2PRESS NEWSWIRE) — Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine.
Archive | Drugs and Pharmaceuticals
Press Release: Myrio Therapeutics and Pure MHC, LLC Announce Research Collaboration to Develop Novel, Targeted Antibody-Based Cancer Therapies
By Send2Press Newswire on April 6, 2022 in Alliances and Partnerships, Biotechnology, Business, Drugs and Pharmaceuticals, OKLAHOMA CITY, Okla., Press Releases
OKLAHOMA CITY, Okla., AUSTIN, Texas and MELBOURNE, Australia, April 6, 2022 (SEND2PRESS NEWSWIRE) — Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC’s proprietary offering of MHC peptide targets for oncology with Myrio’s revolutionary Retained Display(tm) (ReD) antibody discovery […]
Press Release: Geminid Systems Unveils Pharmalite CRM to Boost Remote Engagement of Pharma Field Teams
By Send2Press Newswire on December 9, 2021 in Business, Drugs and Pharmaceuticals, Press Releases, Product Launches, REDWOOD CITY, Calif., Software, Technology
REDWOOD CITY, Calif., Dec. 9, 2021 (SEND2PRESS NEWSWIRE) — Geminid Systems, Inc. today announced the global rollout of a SaaS super-app that aims to improve pharmaceutical operations by helping field teams easily overcome challenges arising from the ongoing COVID pandemic.
Press Release: iCell Gene Therapeutics Announces cCAR-T Clinical Publication in the Stem Cell Reviews and Reports Journal
By Send2Press Newswire on September 10, 2021 in Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases, Reports and Studies
STONY BROOK, N.Y., Sept. 10, 2021 (SEND2PRESS NEWSWIRE) — iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, today announced the publication of their clinical study utilizing cCAR T-cell immunotherapy to successfully treat a patient with lupus.
Press Release: Kalyagen Announces Release of Free eBook on How to Optimize Health Using Stem Cells
By Send2Press Newswire on July 14, 2021 in AUSTIN, Texas, Books and Publishing, Business, Drugs and Pharmaceuticals, Press Releases
AUSTIN, Texas, July 14, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® has announced the release and availability of a free eBook, “The Stemregen Effect – Tapping into the Power of Your Own Stem Cells,” which provides an overview of how stem cells are the body’s repair system and how STEMREGEN®, a natural stem cell enhancer, has been […]
Press Release: Live-Online C. diff. Symposium developed to support and guide patients, families, and caregivers through a C. difficile illness
By Send2Press Newswire on June 29, 2021 in Business, Drugs and Pharmaceuticals, NonProfit and Charities, Press Releases, TAMPA, Fla.
TAMPA, Fla., June 29, 2021 (SEND2PRESS NEWSWIRE) — The C Diff Foundation will host a free, live-online, and interactive symposium on Friday, July 16, 2021 from 1 to 3 p.m. EDT. Sponsored by Seres Therapeutics, the event is designed for patients who are being treated for a C. diff. infection (CDI) in addition to those […]
Press Release: Pure MHC, LLC Announces Launch of its Peptide HLA Immunotherapy Data Resource following Collaboration with LifeNet Health
By Send2Press Newswire on March 16, 2021 in AUSTIN, Texas, Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases, Product Launches
AUSTIN, Texas, March 16, 2021 (SEND2PRESS NEWSWIRE) — Pure MHC, LLC, a target discovery and development company, today announced the launch of its Peptide HLA Immunotherapy Data Resource (“PHIDR”), built through its collaboration with a trusted provider of transplant solutions and a leader in regenerative medicine, LifeNet Health.
Press Release: Pure Transplant Solutions Announces Collaboration with the University of Alabama at Birmingham to Develop Memory B Cell-Directed Diagnostics for HLA-Sensitized Patients
By Send2Press Newswire on March 11, 2021 in Alliances and Partnerships, Biotechnology, BIRMINGHAM, Ala., Business, Drugs and Pharmaceuticals, Press Releases, Surgery and Neurotechnology
AUSTIN, Texas and BIRMINGHAM, Ala., March 11, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with The University of Alabama […]
Press Release: Zeteo Biomedical Receives US Patent for Innovative Sublingual Delivery Device for Vaccines and Pharmaceuticals
By Send2Press Newswire on March 10, 2021 in AUSTIN, Texas, Business, Drugs and Pharmaceuticals, Patent and Trademark, Press Releases
AUSTIN, Texas, March 10, 2021 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its “Oral Delivery Device and Methods” (US Patent 10238577). This latest patent expands the capabilities of Zeteo’s ZEO Delivery Platform to systemically deliver drugs or biologics, into the […]
Press Release: Caisson Biotech, LLC and Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers
By Send2Press Newswire on February 23, 2021 in AUSTIN, Texas, Biotechnology, Business, Drugs and Pharmaceuticals, Patent and Trademark, Press Releases
AUSTIN, Texas and OKLAHOMA CITY, Okla., Feb. 23, 2021 (SEND2PRESS NEWSWIRE) — Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new […]